Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sangel Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$31M
Portfolio companies 25
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sangel Capital:
Typical Co-investors
Sangel Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sangel Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Buckley Ventures California, San Francisco, United States
CP Ventures Australia, New South Wales, Sydney
Dreadnought Capital Connecticut, Stamford, United States
JRG Capital Partners Chicago, Illinois, United States
ReDefine Capital Partners Colorado, Denver, United States
RevvX Hardware / IOT Accelerator Bangalore, India, Karnataka
Shin-Kong Capital -
Talis France, Ile-de-France, Paris
The Fund (Attorneys' Title Fund Services) Florida, Orlando, United States
TRE Holding Lucerne, Switzerland, Zug

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Proviva Therapeutics, Inc

$18M06 Mar 2024 -

BioTroy Therapeutics

Health Care
Health Diagnostics
Medical
$15M07 Mar 2023 China, China

Yiyao Technology

Health Care
$1M15 Mar 2022 Dongcheng District, Beijing, China

SparX Group

Biopharma
Biotechnology
Health Care
$30M31 Dec 2021 -

10 Mar 2021 Shanghai, China

Ascentawits

$15M11 Feb 2021 Shenzhen, Guangdong, China

Biotechnology
Health Care
07 Jun 2020 Vancouver, British Columbia, Canada

Denovo Biopharma

Biopharma
Biotechnology
Health Care
$46M31 Oct 2019 San Diego, California, United States

Health Care
Medical
04 Apr 2019 Futian District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sangel Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 31
Average round size 31M
Peak activity year 2020
Lead investments 5
Follow on index 0.19
Group Appearance index 0.81

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Proviva Therapeutics, Inc

$18M06 Mar 2024 -

BioTroy Therapeutics

Health Care
Health Diagnostics
Medical
$15M07 Mar 2023 China, China

Yiyao Technology

Health Care
$1M15 Mar 2022 Dongcheng District, Beijing, China

SparX Group

Biopharma
Biotechnology
Health Care
$30M31 Dec 2021 -

10 Mar 2021 Shanghai, China

Ascentawits

$15M11 Feb 2021 Shenzhen, Guangdong, China

Biotechnology
Health Care
07 Jun 2020 Vancouver, British Columbia, Canada

Denovo Biopharma

Biopharma
Biotechnology
Health Care
$46M31 Oct 2019 San Diego, California, United States

Health Care
Medical
04 Apr 2019 Futian District, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: